Ectopic Pregnancy

Ectopic pregnancy occurs when a fertilised ovum implants outside the uterine cavity, most commonly in the fallopian tube, and is a potentially life-threatening gynaecological emergency.

DRCOGPLAB 1UKMLA0 questions

Key Facts

Ectopic pregnancy complicates approximately 1 in 80-90 pregnancies (11 per 1,000) in the UK 97% occur in the fallopian tube (ampulla most common site at 70%) Remains a significant cause of first-trimester maternal death in the UK Classic triad: amenorrhoea, abdominal pain, vaginal bleeding (present in only ~50%) Serum βhCG >1,500 IU/L with no intrauterine pregnancy on TVS is highly suspicious NICE NG126 recommends TVS as first-line investigation for women with pain/bleeding in early pregnancy Methotrexate 50mg/m² IM single dose is used for medically managed ectopic (if βhCG <5,000, no cardiac activity, <35mm mass) Risk factors include previous ectopic (10-15% recurrence), PID, tubal surgery, IVF, IUCD in situ

Overview

Key Facts

Ectopic pregnancy is the implantation of a fertilised ovum outside the endometrial cavity. It is a common and potentially life-threatening condition requiring prompt diagnosis and management. Early recognition is essential to prevent tubal rupture and haemodynamic compromise.

Epidemiology

  • Incidence: approximately 11 per 1,000 pregnancies in the UK
  • Accounts for 0.5% of maternal deaths in the UK
  • Peak incidence at age 25-34 years
  • Incidence rising due to increased prevalence of risk factors and earlier detection

Aetiology

  • Tubal factors: previous PID/salpingitis (especially Chlamydia trachomatis), previous tubal surgery, previous ectopic pregnancy (10-15% recurrence), tubal endometriosis
  • Contraceptive factors: progesterone-only pill, IUCD/IUS in situ (does not increase absolute risk but proportion of ectopics increases), previous sterilisation failure
  • Assisted reproduction: IVF/ICSI (2-5% ectopic rate)
  • Other: smoking (dose-dependent, 2× risk), age >35 years, history of infertility

Pathophysiology

  • 97% are tubal: ampullary (70%), isthmic (12%), fimbrial (11%), interstitial/cornual (2-4%)
  • Non-tubal sites: ovarian (3%), cervical (<1%), caesarean scar, abdominal/peritoneal (rare)
  • Damaged tubal epithelium (from PID, surgery) impairs ovum transport
  • Growing ectopic erodes into tubal wall and blood vessels
  • Tubal rupture causes intraperitoneal haemorrhage and haemodynamic compromise

Clinical Presentation

Typical Presentation

  • Amenorrhoea (6-8 weeks, though may have irregular bleeding mistaken for a period)
  • Unilateral lower abdominal/pelvic pain
  • Vaginal bleeding (usually scanty, dark brown, 'prune juice')
  • Pain may be intermittent or constant

Ruptured Ectopic

  • Sudden severe abdominal pain
  • Shoulder tip pain (diaphragmatic irritation from haemoperitoneum)
  • Haemodynamic compromise: tachycardia, hypotension, syncope
  • Peritonism: guarding, rebound tenderness
  • Cervical excitation on bimanual examination

Red Flags

  • Haemodynamic instability (tachycardia, hypotension)
  • Shoulder tip pain
  • Syncope or collapse
  • Peritonism
  • Positive pregnancy test with acute abdomen

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
Miscarriage (threatened/incomplete)Crampy central pain, heavier bleeding, open osTVS, serial βhCG
Ovarian cyst accident (rupture/torsion)Sudden unilateral pain, may be haemodynamically unstablePelvic USS, pregnancy test
Corpus luteum cystUnilateral pain in early pregnancy, may ruptureTVS
AppendicitisRIF pain, anorexia, fever, raised WCCUSS, CT if needed
Urinary tract infection/renal colicDysuria, haematuria, loin-to-groin painUrinalysis, USS KUB
Pelvic inflammatory diseaseBilateral pain, vaginal discharge, feverHVS, blood cultures

Diagnosis / Investigation

Bedside

  • Urine pregnancy test (highly sensitive, positive in >99%)
  • Observations: HR, BP, temperature
  • Urinalysis

Bloods

  • Serum βhCG: essential for management decisions; level >1,500 IU/L (discriminatory zone) without intrauterine pregnancy on TVS is highly suspicious
  • Serial βhCG at 48 hours: in normal IUP, rises by ≥63%; in ectopic, often rises <63% or plateaus/falls
  • FBC (haemoglobin for haemorrhage assessment)
  • Group and save / crossmatch if haemodynamically unstable
  • Serum progesterone: <20 nmol/L suggests non-viable pregnancy (limited utility)

Imaging

  • Transvaginal ultrasound (TVS): first-line investigation (NICE NG126)
    • Intrauterine pregnancy visible from βhCG ~1,000-1,500 IU/L
    • Ectopic findings: adnexal mass, 'blob sign', 'bagel sign', tubal ring, free fluid in POD
    • Empty uterus with positive pregnancy test = pregnancy of unknown location (PUL)

Special Tests

  • Diagnostic laparoscopy: definitive if diagnosis uncertain and patient symptomatic

Management

Non-pharmacological

  • Expectant management: suitable if βhCG <1,500 IU/L and declining, asymptomatic, able to return for follow-up
  • Patient information: ectopic pregnancy warning symptoms, when to attend A&E
  • Psychological support: early pregnancy loss counselling

Pharmacological

  • Methotrexate 50mg/m² IM single dose:
    • Criteria: confirmed ectopic, βhCG <5,000 IU/L (some centres <3,000), no significant pain, adnexal mass <35mm, no fetal cardiac activity, no intrauterine pregnancy
    • Monitor βhCG on days 4 and 7: need ≥15% drop between days 4-7
    • If insufficient decline, consider second dose or surgery
    • Advise reliable contraception for 3 months after methotrexate (teratogenic)
    • Anti-D immunoglobulin for RhD-negative women if surgical management

Surgical/Interventional

  • Laparoscopic salpingectomy: first-line surgical treatment (preferred if contralateral tube is healthy)
  • Laparoscopic salpingotomy: considered if contralateral tube is damaged/absent (fertility-sparing); requires serial βhCG follow-up for persistent trophoblast
  • Emergency laparotomy: for ruptured ectopic with haemodynamic instability

Referral Criteria

  • All suspected ectopic pregnancies require urgent assessment in an early pregnancy assessment unit (EPAU)
  • Emergency surgical referral if haemodynamically unstable
  • Follow-up with serial βhCG until <5 IU/L (expectant or medical management)

Prognosis

  • Maternal mortality: 0.2 per 1,000 ectopic pregnancies in the UK (significantly improved with early detection)
  • Success rate of methotrexate (single dose): 65-95% (higher with lower initial βhCG)
  • Subsequent intrauterine pregnancy rate: 60-70% after salpingectomy, 70-80% after salpingotomy
  • Recurrence risk: 10-15% after one ectopic; 25% after two
  • Persistent trophoblast after salpingotomy: 5-20% (requires serial βhCG monitoring)

Other Relevant Information

Management Pathway Summary

ParameterExpectantMedical (MTX)Surgical
βhCG<1,500 and declining<5,000Any level
SymptomsMinimalMinimal painAny symptoms
Mass size<35mm<35mmAny size
Cardiac activityNoNoYes or No
Follow-upSerial βhCGDay 4 and 7 βhCGHistology + βhCG

βhCG Interpretation in Early Pregnancy

PatternLikely Diagnosis
Doubling every 48h (≥63% rise)Viable IUP
Rising <63% in 48hEctopic pregnancy
Declining >50% in 48hMiscarriage
Plateau or slow declineEctopic or retained products